<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.rapidgenebio.com/p/explorna-and-the-evidence-needed</loc><news:news><news:publication><news:name>RapidGene Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-27T19:51:46+00:00</news:publication_date><news:title>ExploRNA and the evidence needed to adopt a GMP cap reagent</news:title></news:news></url><url><loc>https://www.rapidgenebio.com/p/arcturus-plans-arct-2601-what-carries</loc><news:news><news:publication><news:name>RapidGene Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-27T19:46:24+00:00</news:publication_date><news:title>Arcturus plans ARCT-2601: what carries over from ARCT-810?</news:title></news:news></url><url><loc>https://www.rapidgenebio.com/p/fdas-expedited-ind-pilot-a-cmc-readiness</loc><news:news><news:publication><news:name>RapidGene Insights</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-27T09:10:32+00:00</news:publication_date><news:title>FDA’s Expedited IND Pilot: A CMC Readiness Test for First-in-Human Programs</news:title></news:news></url></urlset>